Pycnodysostosis (PYCD) is an autosomal recessive lysosomal storage disorder of the bone which leads to stereotypical abnormalities consisting of, but not limited to, sclerotic and fragile bone, shortened distal phalanges, and obtuse mandibular angle. Current literature describes the otolaryngological manifestations and treatment of this disorder; however, the treatment of orthopedic fractures in PYCD patients is seldom described and remains a controversial topic. We aim to systematically review the current evidence regarding the optimal treatment of PYCD patients with fractures. We performed a literature search using PubMed, MEDLINE, Web of Science, and Google Scholar databases. Elig-ibility criteria consisted of English-language literature of PYCD patients undergoing treatment for orthopedic surgery fractures. Non-English papers or literature focused on maxillofacial manifestations/treatment were excluded. The database search resulted in the identification of 500 articles. After removing duplicates and enforcing our inclusion criteria, 29 case reports/series (40 patients) were included. The average age was 31.25 (-±18.2) years, with 57.5% of patients being female. Overall, 62.5% of patients had consanguineous parents. Additionally, 86.2% reported a history of previous fractures while 47.5% reported a spontaneous or minor trauma fracture, with most fractures occurring in the femur (60.0%) and tibia (40.0%). Radiographic features consisted of densification in the femur 45.0% (18/40), tibia 37.5% (15/40), and spine 25.0% (10/40). Overall, 84.2% of patients were treated with surgical management consisting of internal plate fixation (IPF) (48.3%), intramedullary fixation (20.7%), and Ilizarov external fixation (IEF) (13.8%). Overall, the refracture rate was 25.0% and was lowest in intramedullary fixation (0/6), compared to IPF (3/14) and IEF (3/4). Average time until refracture was 40.6 months (3-132 months). Long-term follow-up is recommended in patients with PYCD due to the propensity for fractures/refractures. While this study provides the groundwork for the treatment of PYCD patients, further research with higher-evidence studies should be conducted to establish the optimal orthopedic treatment of this disorder.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119195 | PMC |
| http://dx.doi.org/10.7759/cureus.24275 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Case Report: A Novel Homozygous Variant of the Gene in Rare Pycnodysostosis.
Int J Mol Sci
December 2024
Research Institute of Medical Genetics, Tomsk National Research Medical Center, Tomsk 634050, Russia.
Pycnodysostosis (PD) is a rare autosomal recessive skeletal dysplasia from impaired bone resorption due to osteoclastic dysfunction. The features of PD are deformity of the skull, maxilla, and phalanges; osteosclerosis; and bone fragility. We describe the case of a patient with complaints of multiple fractures of the lower extremities in the anamnesis and pain in the lower extremities, cervical spine, and shoulder girdle during physical exertion.
View Article and Find Full Text PDFPycnodysostosis and severe laryngomalacia complicating general anesthesia: A case report.
Saudi J Anaesth
October 2024
Anesthesiology Departament, Instituto José Frota, Fortaleza, Ceará, Brazil.
Pycnodysostosis is a very rare autosomal recessive disease. This disorder presents with osteosclerosis, leading to fragile bones, short stature, craniofacial abnormalities, laryngomalacia, sleep apnea syndrome, and many other findings. Difficulty intubation is very common.
View Article and Find Full Text PDFPycnodysostosis: Clinical Insights From Two Siblings.
Cureus
September 2024
Department of Pediatrics, Mohammed VI University Hospital, Oujda, MAR.
Pycnodysostosis is a rare autosomal recessive bone disorder caused by mutations in the cathepsin K (CTSK) gene, characterized by increased bone density, short stature, and skeletal fragility. This study reports on two siblings from a consanguineous marriage, observed at the Mohammed VI University Hospital in Oujda, Morocco. Both patients presented with typical symptoms, including craniofacial dysmorphism and skeletal abnormalities.
View Article and Find Full Text PDFLatent metabolic bone disease, skeletal dysplasia and other conditions related to low bone formation among 38 patients with subtrochanteric femoral fractures: a retrospective observational study.
Osteoporos Int
September 2024
Division of Nephrology and Endocrinology, The University of Tokyo Hospital, Tokyo, Japan.
Article Synopsis
- - A study analyzed 38 patients with rare subtrochanteric femoral fractures to identify underlying metabolic bone diseases associated with low bone formation, revealing that 4 of them had such disorders.
- - The research aimed to evaluate the prevalence of risk factors like age, glucocorticoid use, and antiresorptive agents among the patients, many of whom were older adults with a history of these medications.
- - Key findings included that some patients were diagnosed with specific conditions like hypophosphatemic osteomalacia and a genetic variant linked to bone health, emphasizing the need for clinicians to investigate latent bone diseases in patients with atypical femoral fractures.
Effects and Safety of Growth Hormone Treatment in Six Children with Pycnodysostosis.
Horm Res Paediatr
June 2024
Dutch Growth Research Foundation, Rotterdam, The Netherlands.
Introduction: Pycnodysostosis is an extremely rare skeletal dysplasia caused by cathepsin K deficiency. It is characterized by extreme short stature with adult height (AH) in males typically less than 150 cm and in females less than 130 cm. Our objective was to evaluate the effect and safety of growth hormone (GH) treatment in 6 patients with pycnodysostosis treated according to the Dutch national pycnodysostosis guideline.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!